SCHEMBL21032196

SCHEMBL21032196

CCOC(=O)c1ccc(S(=O)(=O)Cl)c(Br)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 4/20 0.50
CA2 P00918 4/20 0.50
CA12 O43570 3/20 0.50
CA7 P43166 3/20 0.50
CA9 Q16790 3/20 0.50
CA14 Q9ULX7 3/20 0.50
ALDH1A1 P00352 1/20 0.49
ESR1 P03372 2/20 0.46
ESR2 Q92731 1/20 0.46
HPGD P15428 2/20 0.46
HSD17B2 P37059 1/20 0.46
RECQL P46063 1/20 0.46
STS P08842 1/20 0.46
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
MAOA P21397 1/20 0.45
NHERF1 O14745 1/20 0.45
KMT2A Q03164 2/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL120300 0.84 ALDH1A1 (0.56) CA1CA2CA12CA7CA9
SCHEMBL21032197 0.83 NHERF1 (0.49) CA1CA2CA12CA7CA9
SCHEMBL3165834 0.82 CA1 (0.50) CA1CA2CA12CA7CA9
SCHEMBL9879781 0.82 LMNA (0.53) CA1CA2CA12CA7CA9
SCHEMBL9654463 0.81 CA1 (0.49) CA1CA2CA12CA7CA9
SCHEMBL3471632 0.81 ALDH1A1 (0.67) CA1CA2CA12CA7CA9
SCHEMBL22468902 0.79 CA12 (0.61) CA1CA2CA12CA7CA9
SCHEMBL30375337 0.78 CA12 (0.56) CA1CA2CA12CA7CA9
SCHEMBL3030169 0.78 CA12 (0.56) CA1CA2CA12CA7CA9
SCHEMBL7621544 0.78 HSD17B2 (0.58) CA1CA2CA12CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3489233-B1 INDOLE DERIVATIVE USED AS CRTH2 INHIBITOR CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN) 2022-01-12 EP disclosed
EP-3489233-A1 INDOLE DERIVATIVE USED AS CRTH2 INHIBITOR Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) 2019-05-29 EP disclosed